Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Abdulrahman Alsaedy"'
Autor:
Hajar AlQahtani, Sara AlBilal, Ebrahim Mahmoud, Omar Aldibasi, Ahmad Alharbi, Nour Shamas, Abdulrahman Alsaedy, Kenana Owaidah, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Hatim Arishi, Saleem Baharoon, Mohammad Bosaeed
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 36-41 (2022)
Introduction: Immunomodulators, including dexamethasone (DEX), have been recommended by the Infectious Disease Society of America (IDSA) to treat moderate, severe, and critical COVID-19. Tocilizumab (TCZ) was added to the treatment recommendations ba
Externí odkaz:
https://doaj.org/article/192cbf0901c64e21ab23483d30a99fba
Autor:
Moayad Alqurashi, Abdulrahman Alsaedy, Bassam Alalwan, Maha Alzayer, Abdulrahman Alswaji, Liliane Okdah, Michel Doumith, Hosam Zowawi, Sameera Aljohani, Majed Alghoribi
Publikováno v:
Pathogens, Vol 11, Iss 12, p 1475 (2022)
Pseudomonas otitidis is a rare and unique species among the Pseudomonas genus that has not been previously reported as a cause of male genitourinary tract infection. In this report, we describe a case of a 20-year-old immunocompetent male who present
Externí odkaz:
https://doaj.org/article/20e3dddadd4041c6b62df8e07696eea2
Autor:
Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and on
Externí odkaz:
https://doaj.org/article/8f441ec800cb484883e31233e4f0a063
Autor:
Thamer H. Alenazi, Bashayer S. Alanazi, Abdulrahman Alsaedy, Abdulmoneim Khair, Rifat Solomon, Sameera M. Al Johani
Publikováno v:
Journal of Infection and Public Health, Vol 12, Iss 2, Pp 285-288 (2019)
Human immunodeficiency virus (HIV) infection usually presents with a wide range of manifestations. Although HIV patients are prone to pulmonary infections by opportunistic pathogens in the late stage of AIDS, manifesting the disease with pulmonary in
Externí odkaz:
https://doaj.org/article/e37e056a5ada4ebd92981c8825a51cfa
Autor:
Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani
Publikováno v:
BMJ Open, Vol 11, Iss 4 (2021)
Introduction A novel coronavirus, designated SARS-CoV-2, caused an international outbreak of a respiratory illness, termed COVID-19 in December 2019. There is a lack of specific therapeutic agents based on evidence for this novel coronavirus infectio
Externí odkaz:
https://doaj.org/article/5716984f767441f49fc491a9f6532e6c
Autor:
Israa Saib, Saud Aleisa, Husam Ardah, Ebrahim Mahmoud, Ahmad O. Alharbi, Abdulrahman Alsaedy, Sameera Aljohani, Ahmed Alshehri, Naif Khalaf Alharbi, Mohammad Bosaeed
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1549 (2021)
Human coronaviruses (HCoVs) have become evident sources of human respiratory infections with new emerging HCoVs as a significant cause of morbidity and mortality. The common four coronaviruses (229E, HKU1, NL63, and OC43) are known to cause respirato
Externí odkaz:
https://doaj.org/article/7549c84b388a4b46a4a0735864f59315
Autor:
Abdullah Algwizani, Mohammad Alzunitan, Ahmad Alharbi, Abdulrahman Alsaedy, Sameera Aljohani, Bassam Alalwan, Jawaher Gramish, Adel Alothman
Publikováno v:
Journal of Infection and Public Health, Vol 11, Iss 6, Pp 793-795 (2018)
Introduction: Carbapenem-resistant organisms have become major healthcare-associated pathogens and are responsible for significant morbidity and mortality worldwide. Cases and managements: This case-series describes our experience with ceftazidime–
Externí odkaz:
https://doaj.org/article/0a4b9da2c963455c87d56b4068fe6de2
Autor:
Abdulrahman Alsaedy, Mohammad Bosaeed, Kenana Owaida, Saleem Baharoon, Omar Aldibasi, Hatim Arishi, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Nour Shamas, Ebrahim Mahmoud, Sara AlBilal, Hajar AlQahtani, Ahmad Alharbi
Publikováno v:
Journal of Infection and Public Health
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 36-41 (2022)
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 36-41 (2022)
Introduction Immunomodulators, including dexamethasone (DEX), have been recommended by the Infectious Disease Society of America (IDSA) to treat moderate, severe, and critical COVID-19. Tocilizumab (TCZ) was added to the treatment recommendations bas
Publikováno v:
Cureus.
Publikováno v:
Cureus.